Defining Which Remission Criterion At Month 6 Predicts Remission At Month 12 In A Real Life Clinical Practice, In A Cohort Of Ankylosing Spondylitis Patients Treated With Etanercept (Enbrel (Registered))
Phase of Trial: Phase IV
Latest Information Update: 18 Apr 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms REACH AS
- Sponsors Pfizer
- 07 Jun 2017 Biomarkers information updated
- 11 Apr 2017 Planned End Date changed from 1 Mar 2017 to 30 Apr 2017.
- 11 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 30 Apr 2017.